Award
Indiana University Indianapolis 5R01CA266699-05
Targeting SUMO1 degradation for advanced colon cancer therapy
Recipient
Indiana University Indianapolis
Award Amount
$356,986.00
Ceiling
$356,986.00
Awarded
June 16, 2026
Identifier
5R01CA266699-05
NIH grant awarded to Indiana University Indianapolis for research on SUMO1 degradation as a therapy for advanced colon cancer, including preclinical and molecular studies.
Description
This is a NIH grant project for research on SUMO1 degradation in colon cancer therapy, involving preclinical studies, in vivo testing, and molecular mechanism analysis.